---
title: "Lung Cancer Clinical Trials in California"
description: "Find 1,470 clinical trials for lung cancer near California. Connect with research centers in your area."
url: "https://www.clareohealth.com/clinical-trials/condition/lung-cancer/california"
---

# Lung Cancer Clinical Trials in California

Find 1,470 clinical trials for lung cancer near California. Connect with research centers in your area.

- [All Lung Cancer trials nationwide](https://www.clareohealth.com/clinical-trials/condition/lung-cancer)
- [All trials in California](https://www.clareohealth.com/clinical-trials/location/california)

Showing 1-20 of 1,470 trials

### [Sorafenib in Treating Patients With Refractory Non-Small Cell Lung Cancer](https://www.clareohealth.com/clinical-trials/NCT00064350)

Status: COMPLETED · Phase: PHASE2 · NCT00064350 · Stanford, California and 140 others · Sponsor: Eastern Cooperative Oncology Group

RATIONALE: Preclinical studies indicate that sorafenib is a potent inhibitor of Raf kinase in vitro and in vivo, with significant dose-dependent, anti-tumor activity in four differ…

### [Evaluation of FKB238 and Avastin in Patients With Advanced/Recurrent Non-squamous Non-small Cell Lung Cancer](https://www.clareohealth.com/clinical-trials/NCT02810457)

Status: COMPLETED · Phase: PHASE3 · NCT02810457 · Fountain Valley, California and 146 others · Sponsor: Centus Biotherapeutics Limited

The purpose of this research study is to compare the effectiveness and safety of FKB238 against Avastin® in men and women with advanced/recurrent non squamous non-small cell lung c…

### [Study of Erlotinib (Tarceva®) in Combination With OSI-906 in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) With Activating Mutations of the Epidermal Growth Factor Receptor (EGFR) Gene](https://www.clareohealth.com/clinical-trials/NCT01221077)

Status: COMPLETED · Phase: PHASE2 · NCT01221077 · La Jolla, California and 28 others · Sponsor: Astellas Pharma Inc

A multicenter, randomized, double-blind, placebo-controlled, phase 2 study of Erlotinib (Tarceva®) in combination with OSI-906 in Patients with Advanced non-small cell lung cancer…

### [A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)](https://www.clareohealth.com/clinical-trials/NCT06568939)

Status: RECRUITING · Phase: PHASE2 · NCT06568939 · Chandler, Arizona and 82 others · Sponsor: AbbVie

Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably.

### [Sacituzumab Tirumotecan (MK-2870) Versus Pemetrexed and Carboplatin Combination Therapy in Participants With Epidermal Growth Factor (EGFR)-Mutated, Advanced Nonsquamous Non-small Cell Lung Cancer (NSCLC) Who Have Progressed on Prior EGFR Tyrosine Kinase Inhibitors (MK-2870-009)](https://www.clareohealth.com/clinical-trials/NCT06305754)

Status: ACTIVE_NOT_RECRUITING · Phase: PHASE3 · NCT06305754 · Oakland, California and 155 others · Sponsor: Merck Sharp & Dohme LLC

The purpose of this study is to evaluate sacituzumab tirumotecan versus pemetrexed in combination with carboplatin for the treatment of epidermal growth factor receptor (EGFR)-muta…

### [Celecoxib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer](https://www.clareohealth.com/clinical-trials/NCT00072072)

Status: COMPLETED · Phase: PHASE1 · NCT00072072 · Los Angeles, California · Sponsor: Jonsson Comprehensive Cancer Center

RATIONALE: Celecoxib may stop the growth of cancer by stopping blood flow to the tumor.

### [A Trial To Find Out If Vidutolimod Together With Cemiplimab Is Safe And If It Works In Adult Participants With Advanced Cancer Or Metastatic Cancer](https://www.clareohealth.com/clinical-trials/NCT04916002)

Status: TERMINATED · Phase: PHASE2 · NCT04916002 · Birmingham, Alabama and 23 others · Sponsor: Regeneron Pharmaceuticals

The goal of this study is to learn if giving cemiplimab and vidutolimod together could be effective in treating advanced cancer.

### [Treatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With Cancer](https://www.clareohealth.com/clinical-trials/NCT03939481)

Status: ACTIVE_NOT_RECRUITING · NCT03939481 · Antioch, California and 168 others · Sponsor: SWOG Cancer Research Network

This trial studies treatment effects on development of chemotherapy-induced peripheral neuropathy in patients with cancer.

### [Sunitinib Malate as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy](https://www.clareohealth.com/clinical-trials/NCT00693992)

Status: COMPLETED · Phase: PHASE3 · NCT00693992 · Anniston, Alabama and 483 others · Sponsor: National Cancer Institute (NCI)

This randomized phase III trial studies sunitinib malate to see how well it works when given as maintenance therapy (meaning it is approved for treatment after chemotherapy) in pat…

### [Study of Dovitinib and Biomarkers in Advanced Non-Small Cell Lung Cancer or Advanced Colorectal Cancer](https://www.clareohealth.com/clinical-trials/NCT01676714)

Status: COMPLETED · Phase: PHASE2 · NCT01676714 · Sacramento, California · Sponsor: University of California, Davis

The purpose of this study is to find out if dovitinib is an effective treatment for patients with advanced lung cancer or advanced colorectal cancer (CRC) who have progressed on an…

### [Risk-adapted, Proteomic-guided Systemic Therapy for Previously Untreated Advanced Non-small Cell Lung Cancer](https://www.clareohealth.com/clinical-trials/NCT07250477)

Status: RECRUITING · Phase: PHASE2 · NCT07250477 · Chico, California and 3 others · Sponsor: University of California, Davis

This is a phase 2, pragmatic, 1:1 randomized, open-label study that evaluates risk-adapted, proteomic-guided systemic therapy to improve 12-month progression free survival (PFS) am…

### [Study of Pegilodecakin (LY3500518) With Nivolumab Compared to Nivolumab Alone Second-line Tx in Participants With Metastatic Non-Small Cell Lung Cancer](https://www.clareohealth.com/clinical-trials/NCT03382912)

Status: TERMINATED · Phase: PHASE2 · NCT03382912 · Tempe, Arizona and 34 others · Sponsor: Eli Lilly and Company

To compare the efficacy of pegilodecakin in combination with nivolumab versus nivolumab alone in participants with metastatic non-small cell lung cancer as measured by objective re…

### [Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer](https://www.clareohealth.com/clinical-trials/NCT00979212)

Status: COMPLETED · Phase: PHASE2 · NCT00979212 · Carmichael, California and 30 others · Sponsor: Radiation Therapy Oncology Group

RATIONALE: Drugs used in chemotherapy (CT), such as paclitaxel and carboplatin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping…

### [A Study to Investigate the Efficacy of Durvalumab Plus Tremelimumab in Combination With Chemotherapy Compared With Pembrolizumab in Combination With Chemotherapy in Metastatic NSCLC Patients With Non-squamous Histology Who Have Mutations and/or Co-mutations in STK11, KEAP1, or KRAS](https://www.clareohealth.com/clinical-trials/NCT06008093)

Status: ACTIVE_NOT_RECRUITING · Phase: PHASE2 · NCT06008093 · Beverly Hills, California and 46 others · Sponsor: AstraZeneca

The purpose of the study is to assess the efficacy of durvalumab plus tremelimumab in combination with chemotherapy compared with pembrolizumab in combination with chemotherapy in…

### [Placebo-controlled Study Comparing Niraparib Plus Pembrolizumab Versus Placebo Plus Pembrolizumab as Maintenance Therapy in Participants With Advanced/Metastatic Non-Small Cell Lung Cancer](https://www.clareohealth.com/clinical-trials/NCT04475939)

Status: COMPLETED · Phase: PHASE3 · NCT04475939 · Fullerton, California and 187 others · Sponsor: GlaxoSmithKline

This is a multicenter, randomized, double-blind, placebo-controlled study of niraparib plus pembrolizumab versus placebo plus pembrolizumab as maintenance therapy in participants w…

### [Captopril in Treating Patients With Non-Small Cell Lung Cancer or Limited-Stage Small Cell Lung Cancer That Has Been Previously Treated With Radiation Therapy With or Without Chemotherapy](https://www.clareohealth.com/clinical-trials/NCT00077064)

Status: TERMINATED · Phase: PHASE2 · NCT00077064 · Birmingham, Alabama and 86 others · Sponsor: Radiation Therapy Oncology Group

RATIONALE: Captopril is a drug that may be able to decrease side effects caused by radiation therapy, and may improve the quality of life of patients with non-small cell lung cance…

### [Study of Enzastaurin Versus Placebo With Pemetrexed for Participants With Advanced or Metastatic Lung Cancer](https://www.clareohealth.com/clinical-trials/NCT00530621)

Status: COMPLETED · Phase: PHASE2 · NCT00530621 · Fayetteville, Arkansas and 24 others · Sponsor: Eli Lilly and Company

The purpose of this study is to determine if the combination of enzastaurin and pemetrexed can extend survival time without progression of disease for participants who have advance…

### [Oral HYCAMTIN Plus Whole Brain Radiation Therapy In Treatment Of Brain Metastases Resulting From Non-Small Lung Cancer](https://www.clareohealth.com/clinical-trials/NCT00390806)

Status: COMPLETED · Phase: PHASE3 · NCT00390806 · Birmingham, Alabama and 87 others · Sponsor: GlaxoSmithKline

The current prognosis for patients with metastatic brain cancer from NSCLC is very poor. The current standard treatment for this disease is radiation therapy to the brain.

### [Safety and Tolerability Study of ISIS EIF4E Rx in Combination With Carboplatin and Paclitaxel](https://www.clareohealth.com/clinical-trials/NCT01234038)

Status: COMPLETED · Phase: PHASE1/PHASE2 · NCT01234038 · Birmingham, Alabama and 28 others · Sponsor: Ionis Pharmaceuticals, Inc.

The purpose of this study is to examine the overall survival of patients with Stage IV non-small cell lung cancer (NSCLC) treated with ISIS EIF4E Rx in combination with carboplatin…

### [Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer](https://www.clareohealth.com/clinical-trials/NCT00008385)

Status: COMPLETED · Phase: PHASE3 · NCT00008385 · Mobile, Alabama and 531 others · Sponsor: ECOG-ACRIN Cancer Research Group

RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development or recurrence of cancer.

## Lung Cancer Trials in Other Cities

- [New York](https://www.clareohealth.com/clinical-trials/condition/lung-cancer/new-york)
- [Los Angeles](https://www.clareohealth.com/clinical-trials/condition/lung-cancer/los-angeles)
- [Chicago](https://www.clareohealth.com/clinical-trials/condition/lung-cancer/chicago)
- [Houston](https://www.clareohealth.com/clinical-trials/condition/lung-cancer/houston)
- [Phoenix](https://www.clareohealth.com/clinical-trials/condition/lung-cancer/phoenix)
- [Philadelphia](https://www.clareohealth.com/clinical-trials/condition/lung-cancer/philadelphia)

## Other Conditions in California

- [Breast Cancer](https://www.clareohealth.com/clinical-trials/condition/breast-cancer/california)
- [Prostate Cancer](https://www.clareohealth.com/clinical-trials/condition/prostate-cancer/california)
- [Colorectal Cancer](https://www.clareohealth.com/clinical-trials/condition/colorectal-cancer/california)
- [Melanoma](https://www.clareohealth.com/clinical-trials/condition/melanoma/california)
- [Leukemia](https://www.clareohealth.com/clinical-trials/condition/leukemia/california)
- [Lymphoma](https://www.clareohealth.com/clinical-trials/condition/lymphoma/california)

Data from [ClinicalTrials.gov](https://clinicaltrials.gov).

---

## Sitemap

This is the Markdown version of https://www.clareohealth.com/clinical-trials/condition/lung-cancer/california.

- [Home](https://www.clareohealth.com/index.md)
- [About](https://www.clareohealth.com/about.md)
- [Pricing](https://www.clareohealth.com/pricing.md)
- [For providers](https://www.clareohealth.com/providers.md)
- [FAQ](https://www.clareohealth.com/faq.md)
- [Blog](https://www.clareohealth.com/blog.md)
- [Clinical trials](https://www.clareohealth.com/clinical-trials.md)
- [Developers](https://www.clareohealth.com/developers.md)
- [Privacy policy](https://www.clareohealth.com/legal/privacy-policy.md)
- [Terms of service](https://www.clareohealth.com/legal/terms-of-service.md)
- [Every page](https://www.clareohealth.com/sitemap.md)
- [About this site, for agents](https://www.clareohealth.com/llms.txt)
